UM-SCC-104: A New human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line

Head and Neck

Volumn 34, Issue 10, 2012, Pages 1480-1491

  Tang, Alice L ^a   Hauff, Samantha J ^a   Owen, John H ^a   Graham, Martin P ^a   Czerwinski, Michael J ^a   Park, Jung Je ^b   Walline, Heather ^a,c   Papagerakis, Silvana ^a   Stoerker, Jay ^c,d   McHugh, Jonathan B ^a   Chepeha, Douglas B ^a   Bradford, Carol R ^a   Carey, Thomas E ^a   Prince, Mark E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Gyeongsang National University   (South Korea)

^c Sequenom Molecular Medicine Laboratory   (United States)

^d AMDX Laboratory Sciences   (United States)

Author keywords

ALDH; cancer stem cells; head and neck cell lines; HNSCC; HPV

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN P53;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER STEM CELL; CASE REPORT; CELL POPULATION; CONTROLLED STUDY; DISEASE MARKER; GENOTYPE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UM SCC 104;

ANIMALS; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; NEOPLASTIC STEM CELLS; PAPILLOMAVIRUS INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION, HETEROLOGOUS;

EID: 84866364082     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21962     Document Type: Article

References (42)

1. Lin CJ, Grandis JR, Carey TE, et al. Head and neck squamous cell carcinoma cell lines: established models and rationale for selection. Head Neck 2007; 29: 163-188. (Pubitemid 46167784)
2. Easty DM, Easty GC, Carter RL, Monaghan P, Butler LJ,. Ten human carcinoma cell lines derived from squamous carcinomas of the head and neck. Br J Cancer 1981; 43: 772-785. (Pubitemid 11071761)
3. Krause CJ, Carey TE, Ott RW, Hurbis C, McClatchey KD, Regezi JA,. Human squamous cell carcinoma. Establishment and characterization of new permanent cell lines. Arch Otolaryngol 1981; 107: 703-710. (Pubitemid 11027726)
4. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
5. Allen CT, Lewis JS Jr, El-Mofty SK, Haughey BH, Nussenbaum B,. Human papillomavirus and oropharynx cancer: biology, detection and clinical implications. Laryngoscope 2010; 120: 1756-1772.
6. Maxwell JH, Kumar B, Feng FY, et al. Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res 2010; 16: 1226-1235.
7. Hafkamp HC, Manni JJ, Haesevoets A, et al. Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer 2008; 122: 2656-2664. (Pubitemid 351631366)
8. Kim SY, Chu KC, Lee HR, Lee KS, Carey TE,. Establishment and characterization of nine new head and neck cancer cell lines. Acta Otolaryngol 1997; 117: 775-784. (Pubitemid 27418213)
9. Sacks PG, Parnes SM, Gallick GE, et al. Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck. Cancer Res 1988; 48: 2858-2866.
10. Kumar B, Cordell KG, Lee JS, et al. EGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 2008; 26: 3128-3137.
11. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-269. (Pubitemid 351480538)
12. Hafkamp HC, Mooren JJ, Claessen SM, et al. P21 Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis. Mod Pathol 2009; 22: 686-698.
13. Reed AL, Califano J, Cairns P, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996; 56: 3630-3633. (Pubitemid 26272001)
14. Hafkamp HC, Speel EJ, Haesevoets A, et al. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer 2003; 107: 394-400. (Pubitemid 37266459)
15. Harris SL, Thorne LB, Seaman WT, Neil Hayes D, Couch ME, Kimple RJ,. Association of p16(INK4a) overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue. Head Neck 2010: 33: 1622-1627.
16. Stenner M, Yosef B, Huebbers CU, et al. Nuclear translocation of beta-catenin and decreased expression of epithelial cadherin in human papillomavirus-positive tonsillar cancer: an early event in human papillomavirus-related tumour progression? Histopathology 2011; 58: 1117-1126.
17. Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555-567. (Pubitemid 350056407)
18. Prince ME, Ailles LE,. Cancer stem cells in head and neck squamous cell cancer. J Clin Oncol 2008; 26: 2871-2875.
19. Prince ME, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 2007; 104: 973-978. (Pubitemid 46154721)
20. Ginestier C, Liu S, Diebel ME, et al. CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest 2010; 120: 485-497.
21. Yang H, Yang K, Khafagi A, et al. Sensitive detection of human papillomavirus in cervical, head/neck, and schistosomiasis-associated bladder malignancies. Proc Natl Acad Sci U S A 2005; 102: 7683-7688. (Pubitemid 40741031)
22. Maxwell JH, Kumar B, Feng FY, et al. HPV-positive/p16-positive/EBV- negative nasopharyngeal carcinoma in white North Americans. Head Neck 2010; 32: 562-567.
23. Brenner JC, Graham MP, Kumar B, et al. Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines. Head Neck 2010; 32: 417-426.
24. Hoffmann TK, Sonkoly E, Hauser U, et al. Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma. Oral Oncol 2008; 44: 1100-1109.
25. Rampias T, Boutati E, Pectasides E, et al. Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells. Mol Cancer Res 2010; 8: 433-443.
26. Wald AI, Hoskins EE, Wells SI, Ferris RL, Khan SA,. Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus. Head Neck 2010; 33: 504-512.
27. Ferris RL, Martinez I, Sirianni N, et al. Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis. Eur J Cancer 2005; 41: 807-815. (Pubitemid 40342563)
28. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-720. (Pubitemid 30365531)
29. Gillison ML,. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 2004; 31: 744-754. (Pubitemid 39602680)
30. Applebaum KM, Furniss CS, Zeka A, et al. Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. J Natl Cancer Inst 2007; 99: 1801-1810. (Pubitemid 351767210)
31. Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008; 100: 407-420. (Pubitemid 351480511)
32. Gwosdz C, Balz V, Scheckenbach K, Bier H,. p53, p63 and p73 expression in squamous cell carcinomas of the head and neck and their response to cisplatin exposure. Adv Otorhinolaryngol 2005; 62: 58-71.
33. Steenbergen RD, Hermsen MA, Walboomers JM, et al. Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line. Cancer Res 1995; 55: 5465-5471.
34. Smith EM, Ritchie JM, Summersgill KF, et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 2004; 96: 449-455. (Pubitemid 38443648)
35. Smeets SJ, Hesselink AT, Speel EJ, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007; 121: 2465-2472. (Pubitemid 350022416)
36. Akervall J, Kurnit DM, Adams M, et al. Overexpression of cyclin D1 correlates with sensitivity to cisplatin in squamous cell carcinoma cell lines of the head and neck. Acta Otolaryngol 2004; 124: 851-857. (Pubitemid 39280213)
37. Masuda M, Suzui M, Yasumatu R, et al. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res 2002; 62: 3351-3355. (Pubitemid 34651376)
38. Wilczynski SP, Lin BT, Xie Y, Paz IB,. Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am J Pathol 1998; 152: 145-156. (Pubitemid 28028055)
39. Clay MR, Tabor M, Owen JH, et al. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck 2010; 33: 1195-1201.
40. Chen ZG,. The cancer stem cell concept in progression of head and neck cancer. J Oncol 2009; 2009: 894064.
41. White JS, Weissfeld JL, Ragin CC, Rossie KM, Martin CL, Shuster M, Ishwad CS, Law JC, Myers EN, Johnson JT, Gollin SM,. The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines. Oral Oncol 2007; 43: 701-712. (Pubitemid 47058372)
42. Ragin CC, Reshmi SC, Gollin SM,. Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line. Int J Cancer 2004; 110: 701-709. (Pubitemid 38746029)